AI-generated summary
The authors tested whether a single session of red and near-infrared light therapy (photobiomodulation) on the arm improves maximal handgrip strength in 15 adults with chronic kidney disease receiving hemodialysis. In this randomized, double-blind, placebo-controlled crossover trial, the authors report that handgrip strength increased after the 60 and 90 J per arm doses but not after placebo or the 120 J per arm dose. The small sample and single-session design limit how far these acute findings can be generalized.
- Participants
- 15
- Who or what was studied
- Adults with chronic kidney disease receiving chronic hemodialysis (mean age 58 years, 10 men and 5 women)
- Wavelengths
- 850 nm
- Limits stated in the abstract
- The study included only 15 volunteers and assessed a single acute session at each dose, so longer-term effects are not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
- Power
- 200 mW
- Total energy
- 120 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Systematic review, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.